Clinical Trials Arena February 7, 2025
Artificial intelligence (AI) could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to benefit from vital treatments. We examine how the technology is advancing production in specific areas and why data is critical.
AI has frequently been in the headlines recently due to its potentially transformative capabilities — and the technology is making a notable difference in cell and gene therapies.
Cell and gene therapies offer hope to patients living with conditions such as cancer, sickle cell disease, and autoimmune conditions. Historically, these therapies have been associated with high costs and lengthy development timelines. However, AI is starting to change all of this. While applications of AI are still in the relatively early stages,...
Today's Sponsors
Today's Sponsor